Bayer AG Is “Determined” to Defend Property Rights After Losing Bid on Humira

Bloomberg -- Bayer AG said it’s “determined to enforce intellectual property” after losing a bid to demand royalties from Abbott Laboratories over U.S. sales of the arthritis drug Humira.